Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share
Biocon shares will be in focus of stock market investors after the company's board of directors announce the opening of the QIP (Qualified Institutional Placement) fundraising on 16 June 2025, according to an exchange filing.
'The Fund Raising Committee has at its meeting held today, i.e. Monday, June 16, 2025 authorizing the opening of the issue,' said Biocon in the BSE filing.
Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
3 hours ago
- Mint
Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share
Biocon shares will be in focus of stock market investors after the company's board of directors announce the opening of the QIP (Qualified Institutional Placement) fundraising on 16 June 2025, according to an exchange filing. 'The Fund Raising Committee has at its meeting held today, i.e. Monday, June 16, 2025, authorizing the opening of the issue,' said Biocon in the BSE filing. The pharma company also approved the floor price of the QIP issue to be at ₹ 340.20 per equity share. Biocon disclosed that the company has the ability to discount the offer further to not more than 5 per cent on the floor price of the QIP issue. 'The company may, at its discretion, offer a discount of not more than 5% on the floor price for the issue,' said Biocon in the exchange filing. The firm will decide the issue price after consultation with the book-running lead managers appointed in relation to the case. Biocon shares closed 0.52 per cent higher at ₹ 357.30 after Monday's stock market session, compared to ₹ 355.45 at the previous stock market close. The company announced the outcome of its board meeting after the market operating hours on 16 June 2025. Shares of the pharmaceutical company have given investors more than 637.35 per cent since its listing in the Indian stock market in 2004. However, the shares lost 6.37 per cent in the last five years. In the last one-year period, the stock has gained 8.71 per cent, and is trading 4.31 per cent higher in the last five stock market sessions. Biocon shares hit their 52-week high level at ₹ 404.60 on 21 January 2025, and the 52-week low level was at ₹ 290.80 on 3 March 2025, according to data collected from the BSE website. The pharma company's market capitalisation (M-Cap) was at ₹ 42,897.44 crore as of the stock market close on Monday, 16 June 2025.
&w=3840&q=100)
Business Standard
4 hours ago
- Business Standard
Cordelia Cruise owner files DRHP, NSEIX inks MoU with CSE, and more
Waterways Leisure Tourism, which operates Cordelia Cruises, has filed its draft red herring prospectus (DRHP) for its initial public offering (IPO). The proposed ₹727-crore IPO will be a fresh issue entirely. The IPO proceeds will be used for payment of deposit/advanced lease rental and monthly lease payments to its step-down subsidiary, Baycruise Shipping. Waterways Leisure Tourism currently operates a cruise vessel, the MV Empress, under the brand name Cordelia Cruises, and since its launch, 549,051 guests have sailed on its cruise vessel, which has covered more than 2,25,079.53 nautical miles along the Indian coastline and surrounding islands as of December 31, 2024. The firm's cruise vessel primarily sails to domestic destinations, including Mumbai, Goa, Kochi, Chennai, Lakshadweep, Visakhapatnam and Puducherry. It also offers international itineraries, including Hambantota, Trincomalee and Jaffna. Centrum Capital, Intensive Fiscal Services and Motilal Oswal Investment Advisors are the book-running lead managers. Biocon launches ₹4,500-cr QIP Biocon has launched a qualified institutions placement (QIP) to raise ₹4,500 crore. The biopharmaceutical firm will issue up to 139 million new shares — 11.6 per cent of the current outstanding equity base. The floor price for the QIP has been set at ₹323.2. Shares of Biocon last closed at ₹357.3, valuing the firm at ₹42,900 crore. The issuance price will be finalised on Thursday, while trading in the new shares will commence from Tuesday. Biocon will use the QIP proceeds to purchase outstanding optionally convertible debentures issued by subsidiary Biocon Biologics. It will also use the proceeds to repay outstanding debt and for general corporate purposes. BofA Securities, Kotak Mahindra and Goldman Sachs are the investment bankers handling the share sale. IFC commits $60 mn to Motilal Oswal Alternates The International Finance Corporation (IFC), a member of the World Bank Group, has signed an agreement to invest $60 million in Motilal Oswal Alternates' India Business Excellence Fund V G (IBEF VG), with an additional $60 million co-investment envelope. The fund, targeting $750 million (with a $150 million green-shoe option), will support 12–16 mid-market companies in consumer, financial services, life sciences and manufacturing sectors, focusing on expansion, job creation and technology adoption, particularly in India's Tier-II and Tier-III cities. Managed by MO Alternates, the private investment arm of Motilal Oswal Financial Services Ltd, IBEF VG aims to bridge the funding gap for small and medium enterprises (SMEs) in underserved regions. IFC will also support the fund in enhancing women's workforce participation through workshops and standards. NSE IX inks MoU with Cyprus Stock Exchange The NSE International Exchange (NSE IX), based in GIFT City, has signed a Memorandum of Understanding (MoU) with the Cyprus Stock Exchange (CSE). The agreement was formalised during a roundtable event held in Limassol, Cyprus, during the official visit of India's Prime Minister Narendra Modi and attended by President of the Republic of Cyprus, Nikos Christodoulides. The MoU establishes a framework for multifaceted collaboration between NSE IX and CSE, focusing on cross and dual listings of financial instruments, joint development of innovative financial products, knowledge and research collaboration, capacity-building initiatives and fintech engagement programmes. PM Modi said: 'I am pleased to know that the Cyprus Stock Exchange and NSE have agreed to collaborate in Gujarat's GIFT City.' RIL sells another 0.89% stake in Asian Paints Siddhant Commercials, a subsidiary of Reliance Industries (RIL) on Monday, sold another 0.89 per cent stake in Asian Paints via block deals. The RIL entity sold 8.5 million shares at Rs 2,207 apiece to ICICI Prudential Mutual Fund for Rs 1,876 crore. Last week, it had sold 35 million shares (3.6 per cent equity) at Rs 2,201 apiece to SBI Mutual Fund for Rs 7,704 crore. At the end of March 2025 quarter, Siddhant held 4.9 per cent stake (47 million shares) of the paints major. AlphaGrep Securities gets in-principle approval for MF foray AlphaGrep Securities, a quantitative investment firm specialising in systematic strategies, has received in-principle approval from the Securities and Exchange Board of India (Sebi) to foray into mutual funds (MFs). AlphaGrep Investment Management (AGIM), the asset management vertical of the financial services firm, will house the proposed MF business. AGIM has an AUM of over Rs 2000 crore and 500+ clients across two CAT III AIFs (long-short), Long Only PMS and GIFT City-domiciled outbound CAT III AIF, the company said.
&w=3840&q=100)
Business Standard
4 hours ago
- Business Standard
Markets snap two-day losing streak, shrug off Israel-Iran conflict
Snapping their two-day losing streak, benchmark indices rose on Monday, driven by gains in banking and technology heavyweights, shrugging off the Iran-Israel conflict. Continued buying by domestic institutional investors (DIIs) also helped underpin gains. Most global markets also ended positive, stoking concerns that traders may be undermining the implications of West Asia tensions. The BSE Sensex closed the session at 81,796, up 678 points or 0.8 per cent, while the NSE Nifty rose to 24,947, gaining 228 points or 0.9 per cent. The total market capitalisation of BSE-listed firms increased by ₹3.3 trillion, reaching ₹451 trillion. DIIs were net buyers of equities worth ₹5,781 crore, while foreign institutional investors (FIIs) sold shares worth ₹2,539 crore. DIIs have been net buyers for 20 consecutive sessions, purchasing shares worth ₹94,500 crore. This marks the longest buying spree since the 29-day period of continuous buying that ended on March 19. HDFC Bank, which rose 0.9 per cent, was the biggest contributor to the Sensex, followed by Infosys, which gained 1.4 per cent. HDFC Bank's stocks rose after Jefferies named the private lender its top pick in a report, citing benefits from easing regulations, lower interest rates, and improved credit growth. The gains were partly attributed to a "buying the dip" strategy, as the stock had declined over 3 per cent the previous week. Despite ongoing attacks between Iran and Israel, crude oil prices stabilised as oil production facilities remained unaffected. The conflict has not yet led to the blockade of the Strait of Hormuz, which handles approximately one-fifth of the world's daily crude shipments. Brent crude was trading below $74, down 1.9 per cent. Gold prices declined by 0.5 per cent, trading at $3,413 per ounce. Analysts expect investors to continue their "buying the dip" approach as long as the conflict does not escalate further and other countries remain uninvolved. "Despite ongoing geopolitical tensions between Israel and Iran, the market moved higher, supported by gains in largecap stocks. Investors maintained their focus on long-term fundamentals amid volatile conditions. Geopolitical developments in West Asia are likely to influence near-term market sentiment, with any signs of de-escalation being closely monitored. Smallcap stocks are expected to underperform in the short term, given their elevated valuations and lack of short-term catalysts," said Vinod Nair, Head of Research at Geojit Financial Services. The market breadth was weak, with 2,151 stocks declining and 1,944 advancing. All but three Sensex stocks gained. Reliance Industries rose 0.76 per cent, and Bharti Airtel gained 1.04 per cent, contributing significantly to Sensex's gains. Tata Motors fell 3.8 per cent — most among Sensex and Nifty components -- after projecting financial year 2026 operating margins of 5 per cent-7 per cent for its luxury unit JLR, below its earlier target of 10 per cent. "The market's resilience amid lingering geopolitical tensions is encouraging. However, participants should remain cautious and not get carried away by a single-day rebound, especially as the index approaches the upper band of its current consolidation range, i.e., the 25,000–25,200 zone. We recommend maintaining a stock-specific trading approach, given the mixed trends across sectors, with a preference for relatively less volatile counters," said Ajit Mishra, SVP of Research at Religare Broking.
